Global COVID-19 Testing Industry

2022-10-09 13:59:48 By : Ms. Phoebe Pang

October 05, 2022 06:57 ET | Source: ReportLinker ReportLinker

New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global COVID-19 Testing Industry" - https://www.reportlinker.com/p06219575/?utm_source=GNW Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year - Global COVID-19 Testing Market to Shrink to $8.0 Billion by 2027 - In the changed post COVID-19 business landscape, global market for COVID-19 Testing estimated at US$19 Billion in the year 2020, is projected to decline to US$8.0 Billion by 2027, declining at a CAGR of -11.8% over the analysis period 2020-2027. - COVID-19 testing has emerged as a large market in a span of few months owing to the large-scale testing across the world. However, with vaccines being launched across the world, the COVID-19 testing market is expected to slowdown in 2021, and decline rapidly in the near future as the global population starts getting vaccinated. The major testing types include RT-PCR tests, rapid antigen tests, and rapid antibody tests. Growth in the global market is primarily being driven by rising incidence of COVID-19 infection and the pressing need for effective and fast testing. Announced as pandemic by the WHO, the rapid spread of the virus across countries has prompted governments to rely on massive testing, which created strong demand for COVID-19 test kits. The market for these tests is further bolstered by unavailability of an effective treatment hitherto, driving people to consider diagnostic testing as a solution to curtail the pandemic. Increase caseloads of COVID-19 owing to non-compliance to specific measures like social distancing has resulted in significant demand for testing. In addition, the requirement of effective detection kits for vulnerable population, including aging people and individuals with the compromised immune system, is propelling the market. On the other hand, short supply of test kits and other components, such as RT-PCR instruments, virus control samples, and swabs, are expected to limit the market growth. Select Competitors (Total 547 Featured) 3D Biomedicine Science & Technology Co., Limited Abbott Laboratories Advaite, Inc. AlphaBiolabs Ltd BGI Genomics Co. Ltd. BioFire Diagnostics LLC BioMedomics Inc Bioscience (Tianjin) Diagnostic Technology Co., LTD Cellex Cepheid Inc. Chembio Diagnostic Systems, Inc. Co-Diagnostics Inc. Dynamiker Biotechnology (Tianjin) Co., Ltd. GenMark Diagnostics, Inc. Hologic, Inc Innovita Biological Technology Co., Ltd Mayo Clinic Laboratories Mylab Discovery Solutions Pvt. Ltd. Ortho Clinical Diagnostics Primerdesign Ltd QIAGEN N.V. Quidel Corporation Randox Laboratories Ltd. F. Hoffmann-La Roche AG Safecare Biotech(Hangzhou) Co., Ltd. SD Biosensor Seegene Inc. Shenzhen Bioeasy Biotechnology Co., Ltd. Siemens Healthineers AG Thermo Fisher Scientific Zhejiang Orient Gene Biotech Co., LTD Read the full report: https://www.reportlinker.com/p06219575/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY Influencer Market Insights World Market Trajectories 1. GLOBAL MARKET OVERVIEW Types of COVID-19 Testing Different Types of Coronavirus Tests Performance Analysis of COVID-19 Tests Rapid Tests Help in Controlling the Virus How Will COVID-19 Testing Change in 2021 Massive Testing to Become a Way of Life COVID-19 to Drive Hospital and Diagnostic Lab Revenues in 2021 COVID-19 Testing Witnesses Staggering Growth Due to Rising Incidence of Corona Virus Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of September 1st, 2021 Total Number of COVID-19 Tests Worldwide in Select Countries: As of September 1st, 2021 Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market Select Approved COVID-19 Molecular Assay Tests Immunoassays to Witness Fastest Growth Increasing Demand for Antibody Tests How Antibody (Serology) Tests Were Approved and Developed Select COVID-19 Immunoassay Kits List of US FDA Approved Antigen Tests Nasopharyngeal/Oropharyngeal Swabs Remain Primary Sample Type Diagnostic Laboratories Constitute the Largest End-use Segment RECENT MARKET ACTIVITY Recent Launches 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS AND ISSUES Rising Incidence of Coronavirus Cases Drive the Need for Testing COVID-19 Most Impacted 18 Countries Worldwide: As on September 1st, 2021 Pandemic Gives Rise to Innovative Partnership Models Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics Increasing Point-of-Care Molecular Testing Accelerated Development and Faster Adoption of New Technologies Expansion of Manufacturing Capacity in Asia and Shift of Supply Positioning for the Future Some Innovative Testing Methods for COVID-19: CRISPR Bioluminescence Testing Lab-on-chip Testing LAMpore Kits Covid-19 NudgeBox Test by DNANudge High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 Rapid Test Kits Market for COVID-19 to Exhibit Exponential Growth Select Approved COVID-19 Rapid Tests Point-of-Care Tests Witness Rapid Growth High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19 Mass Community Testing Holds the Key for Effective COVID-19 Management The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market Innovations and Approvals Portable PoC Test with a Smartphone Reader Saliva Test FDA Approves First Molecular Test for Asymptomatic Patients New Molecular Test N1-STOP-LAMP LumiraDx SARS-CoV-2 Antigen Test Integration of Sophisticated Technology to Drive Market Growth Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing In-home Testing for Covid-19 FDA Authorizes Home Collection Option for LabCorp?s COVID-19 Diagnostic Test A Rapid Genomics Strategy to Trace Coronavirus The pioneering of Rapid Genomics Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic Digital Technologies Gaining Adoption Amid COVID-19 List of COVID-19 Contact Tracing Apps Amazon Offers FDA-Approved COVID-19 Test Alliance of BMGF and Life Science Companies Pledge to Improve Access Ensuring the Perfect Mix of COVID-19 Testing Testing Rate & Average Turnaround Time to Results as Key Metrics Growing Significance of Pooled Testing Participation of Public & Private Sector Avoiding Supply Mismatch Recent Launches New Test Detects SARS-CoV-2 in Less Than Five Minutes New COVID-19 Test Provides Faster Results and Eliminates False Negatives New Rapid Lateral Flow Immunoassay Developed University of California Develops Rapid, Accurate Testing for SARS-CoV-2 Antibodies Abbott Plans Shipment of Tens of Millions of At-Home Coronavirus Tests Costing $25 in Early 2021 Quidel Gains FDA Approval for Sofia 2 Antigen Test Improving Medicine with Innovation and Technology and Massachusetts Institute of Technology Develop COVID-19 Testing Impact Calculator (U.S.) Nanomix Offers eLab COVID-19 Rapid Antigen Test Abbott Receives FDA Approval for BinaxNow Roche Introduces Elecsys® SARS-CoV-2 Antigen test DnaNudge Offers CovidNudge Test Open-Source Toolkit Helps Developing Countries Meet Demand for COVID-19 Diagnostics 3M Joins Hands with MIT?s Sikes Lab to Create Rapid & Affordable COVID-19 Test ZTA Biotech Announces "Breakthrough" Development with Antibody Test Molecular Diagnostics Firm QuantuMDx Group Set to Scale up Production of Rapid PCR COVID-19 Device Mologic Granted CE Mark for Rapid Antigen Test FDA Approves Abbott?s COVID-19 Antigen Test AptameXTM COVID-19 Testing - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) Global Market Prospects and Outlook US and Europe Dominate, Asia-Pacific to Witness Fastest Growth 4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2021 & 2027 Table 3: World Recent Past, Current & Future Analysis for RT-PCR Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 4: World 7-Year Perspective for RT-PCR Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 5: World Recent Past, Current & Future Analysis for Immunoassay Test Strips/Cassettes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 6: World 7-Year Perspective for Immunoassay Test Strips/Cassettes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 7: World Recent Past, Current & Future Analysis for Nasopharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World 7-Year Perspective for Nasopharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 9: World Recent Past, Current & Future Analysis for Oropharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 10: World 7-Year Perspective for Oropharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 11: World Recent Past, Current & Future Analysis for Nasal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 12: World 7-Year Perspective for Nasal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 13: World Recent Past, Current & Future Analysis for Other Specimen Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World 7-Year Perspective for Other Specimen Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 18: World 7-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 Table 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027 III. MARKET ANALYSIS UNITED STATES COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) Market Analysis US Emerges as a Major Market for COVID-19 Tests New Delta Variant Cases Cause Concern Covid-19 Test Supply Chain Issues in the US Challenges Associated with COVID-19 Testing Impact of Surveillance Testing on COVID-19 Test Supply Chain CDC Funding for Covid-19 Vaccination & Testing-Related Activities Escalating Cases of COVID-19 Lead to Spurt in Diagnostic Test Innovations Uptake of At-Home Tests Remains Modest FDA Approves 2 Rapid, At-Home Coronavirus Tests Select Point Of Care Home Tests in the US Pharmacies Now Offering Over-The-Counter Same-day COVID Tests HHS Introduces Pilot Program for Cartridge-based Covid-19 Molecular Test Kits Oura Develops New Smart Ring to Detect Covid-19 Symptoms at Early Stage (Finland) Issues with Existing Testing Options Issues with At-Home and Point-of-Care Rapid Tests Disparate Costs Continue to Plague US Covid-19 Testing With Spike in COVID-19 Cases Roiling Testing Efforts, NIH Eyes on Rapid Tests to Push Capacity Promising Technologies under RADx Program Rapid COVID Tests: Important Tool for Recovery California University Installs Vending Machines to Dispense COVID-19 Testing Kits to Students FDA Assumes Lukewarm Stance to Home Tests despite COVID-19 Testing Lag in US CMS Prioritizes Covid-19 Testing: Announces New Reimbursement Rules CMS Decreases Price for High-Throughput Technology-Based Covid -19 Testing Ageing Demographics: A Major Driving Factor US Elderly Population: Expected Growth Rates Over the Years 2005-2025 NIH Funding US FDA Approved COVID-19 Tests Select US FDA Approved COVID-19 Tests (As of August 31, 2021) Table 21: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 22: USA 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 23: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 24: USA 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 25: USA Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 26: USA 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 CANADA Market Analysis New Cheaper and Faster COVID-19 Rapid Test Kit Obtains Approval Canada Approves First Antigen-Based Rapid COVID-19 Test Government of Ontario Introduces Covid-19 Screening Tests at Toronto Pearson International Airport New Federal Rule in Canada for Air Passengers? COVID-19 Tests Table 27: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 28: Canada 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 29: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 30: Canada 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 31: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 32: Canada 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 JAPAN COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) Market Analysis Japan Moves to Low-Cost PCR Testing Rapid Testing Still Costs a Bomb Medical Clinics Edge Table 33: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 34: Japan 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 35: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 36: Japan 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 37: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: Japan 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 CHINA COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) China?s Qingdao Embarks on Ambitious Mission to Test Entire Population of City for COVID-19 in Five Days Table 39: China Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 40: China 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 41: China Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 42: China 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 43: China Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: China 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 EUROPE COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) Market Analysis COVID-19 Testing Drives Revenue Growth Aging Population: A Prime Growth Driver SELECT CE-IVD APPROVED MOLECULAR ASSAYS FOR COVID-19 Table 45: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 46: Europe 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2021 & 2027 Table 47: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 48: Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 49: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 51: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 52: Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 FRANCE COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) Table 53: France Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 54: France 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 55: France Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: France 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 57: France Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 58: France 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 GERMANY COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) Table 59: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 60: Germany 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 61: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Germany 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 63: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 64: Germany 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 ITALY Table 65: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 66: Italy 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 67: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Italy 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 69: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 70: Italy 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 UNITED KINGDOM COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) Pandemic Exposes Deficiencies in the UK Healthcare System UK Opens New Vaccine Centers to Expand Asymptomatic Covid-19 Testing Mandatory COVID-19 Tests for UK-Bound Travellers Mass Testing Program for COVID-19 Mass Testing in Schools Mass Testing in Cities and Towns New `Mega Labs` to Speed Up COVID-19 Testing in Early 2021 Table 71: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 72: UK 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 73: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: UK 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 75: UK Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 76: UK 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 SPAIN Table 77: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 78: Spain 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 79: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Spain 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 81: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 82: Spain 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 RUSSIA Table 83: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 84: Russia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 85: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Russia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 87: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 88: Russia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 REST OF EUROPE Table 89: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 90: Rest of Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027 Table 91: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Rest of Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027 Table 93: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 94: Rest of Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027 ASIA-PACIFIC COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) Table 95: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR Table 96: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2021 & 2027 Table 97: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Please contact our Customer Support Center to get the complete Table of Contents Read the full report: https://www.reportlinker.com/p06219575/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________